us pharmaceutical increase price
Hetlioz is used by fewer than 1,000 patients. The issue came to the forefront last year when 32-year-old pharmaceutical CEO Martin Shkreli bought a six-decade-old drug called Daraprim and raised the price of one pill from $13.50 to $750.